Patent · US Expired

Methods and compositions for inhibition of angiogenesis

US6228879A · kind A · utility

64Cited by
22References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 1999
Grant dateMay 8, 2001
Priority date
Expiry dateMar 26, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/535
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprise the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.